These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3145196)

  • 1. The human Lyt-3 molecule requires CD8 for cell surface expression.
    DiSanto JP; Knowles RW; Flomenberg N
    EMBO J; 1988 Nov; 7(11):3465-70. PubMed ID: 3145196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of anti-human CD8 beta-specific antibodies using transfectants expressing mixed-species CD8 heterodimers.
    DiSanto JP; Terry LA; Flomenberg N
    J Immunol Methods; 1991 Jul; 141(1):123-31. PubMed ID: 1830894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two Lyt-2 polypeptides arise from a single gene by alternative splicing patterns of mRNA.
    Zamoyska R; Vollmer AC; Sizer KC; Liaw CW; Parnes JR
    Cell; 1985 Nov; 43(1):153-63. PubMed ID: 3935316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formal proof that different-size Lyt-2 polypeptides arise from differential splicing and post-transcriptional regulation.
    Tagawa M; Nakauchi H; Herzenberg LA; Nolan GP
    Proc Natl Acad Sci U S A; 1986 May; 83(10):3422-6. PubMed ID: 3085089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene transfer of the Ly-3 chain gene of the mouse CD8 molecular complex: co-transfer with the Ly-2 polypeptide gene results in detectable cell surface expression of the Ly-3 antigenic determinants.
    Blanc D; Bron C; Gabert J; Letourneur F; MacDonald HR; Malissen B
    Eur J Immunol; 1988 Apr; 18(4):613-9. PubMed ID: 2452747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A human homolog of the mouse CD8 molecule, Lyt-3: genomic sequence and expression.
    Johnson P
    Immunogenetics; 1987; 26(3):174-7. PubMed ID: 3114136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfection of the CD8 alpha gene restores specific target cell lysis: factors that determine the function and the expression of CD8 in a cytotoxic T cell clone.
    Schmidt-Ullrich R; Eichmann K
    Int Immunol; 1990; 2(3):247-56. PubMed ID: 2128468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of accessory molecules in signal transduction of cytolytic T lymphocyte by anti-T cell receptor and anti-Ly-6.2C monoclonal antibodies.
    Leo O; Foo M; Henkart PA; Perez P; Shinohara N; Segal DM; Bluestone JA
    J Immunol; 1987 Dec; 139(11):3556-63. PubMed ID: 3316387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning of Lyt-2, a membrane glycoprotein marking a subset of mouse T lymphocytes: molecular homology to its human counterpart, Leu-2/T8, and to immunoglobulin variable regions.
    Nakauchi H; Nolan GP; Hsu C; Huang HS; Kavathas P; Herzenberg LA
    Proc Natl Acad Sci U S A; 1985 Aug; 82(15):5126-30. PubMed ID: 3927298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cytoplasmic domain of the CD8 alpha-chain is required for its interaction with p56lck.
    Yao L; Nakauchi H; Honjo T; Kawakami T
    Immunol Lett; 1990 Jul; 24(4):267-71. PubMed ID: 2118122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective activation of resting mouse T lymphocytes by cross-linking submitogenic concentrations of the T cell antigen receptor with either Lyt-2 or L3T4.
    Eichmann K; Jönsson JI; Falk I; Emmrich F
    Eur J Immunol; 1987 May; 17(5):643-50. PubMed ID: 3108015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning of Lyt-3, a membrane glycoprotein marking a subset of mouse T lymphocytes: molecular homology to immunoglobulin and T-cell receptor variable and joining regions.
    Nakauchi H; Shinkai Y; Okumura K
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4210-4. PubMed ID: 3035575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking of CTL-mediated killing by monoclonal antibodies to LFA-1 and Lyt-2, 3. II. Evidence that trypsin pretreatment of target cells removes a non-H-2 molecule important in killing.
    Gromkowski SH; Heagy W; Martz E
    J Immunol; 1985 Jan; 134(1):70-7. PubMed ID: 3880579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cis-acting DNA elements and cell type-specific nuclear proteins which may play a role in regulation of mouse CD8 alpha (Lyt-2) gene transcription.
    Lee WH; Banan M; Harriss JV; Hwang I; Woodward E; Youn HJ; Gottlieb PD
    Int Immunol; 1994 Sep; 6(9):1307-21. PubMed ID: 7819139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4 and CD8 regulate interleukin 2 responses of T cells.
    Takahashi K; Nakata M; Tanaka T; Adachi H; Nakauchi H; Yagita H; Okumura K
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5557-61. PubMed ID: 1608966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and properties of new Lyt-congenic strains and anti-Lyt-2.2 and anti-Lyt-3.1 monoclonal antibodies.
    Gottlieb PD; Marshak-Rothstein A; Auditore-Hargreaves K; Berkoben DB; August DA; Rosche RM; Benedetto JD
    Immunogenetics; 1980; 10(6):545-55. PubMed ID: 22457935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconstitution of MHC class I specificity by transfer of the T cell receptor and Lyt-2 genes.
    Gabert J; Langlet C; Zamoyska R; Parnes JR; Schmitt-Verhulst AM; Malissen B
    Cell; 1987 Aug; 50(4):545-54. PubMed ID: 2955903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of Lyt-2 and L3T4 in activation of hapten-specific Lyt-2+ L3T4+ T-cell clones.
    Fazekas de St Groth B; Gallagher PF; Miller JF
    Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2594-8. PubMed ID: 3085100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mediation of in vivo tumor-neutralizing activity by Lyt-2+ as well as L3T4+ T cell subsets.
    Yoshioka T; Sato S; Ogata M; Sakamoto K; Sano H; Shima J; Yamamoto H; Fujiwara H; Hamaoka T
    Jpn J Cancer Res; 1988 Jan; 79(1):91-8. PubMed ID: 2965692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.